VIVUS LLC, a biopharmaceutical company, has an exciting new episode airing on Health Uncensored with Dr. Drew. The show will feature John Amos, the CEO of VIVUS, along with top weight-loss experts discussing QSYMIA®, an oral medication designed for weight management. This episode is set to air on Lifetime on March 19, 2025, at 7:30 AM ET/PT. You can also catch it on the Health Uncensored website.
During the episode, Dr. Drew and his guests, including Dr. Farhad Zangeneh and Dr. Dina Peralta-Reich, will dive into the challenges of managing weight and how QSYMIA can help. Amos highlights the urgency of addressing obesity, noting that global obesity rates could reach one billion by 2030. This worrying trend emphasizes the need for effective solutions in weight management.
QSYMIA combines phentermine and topiramate and is designed to aid weight loss when paired with a reduced-calorie diet and increased exercise. As the leading non-injectable weight-loss medication in the U.S., QSYMIA has garnered attention for its role in treating obesity, which is linked to serious health conditions like diabetes and heart disease.
According to recent data, nearly 42% of adults in the United States are classified as obese. This figure rose significantly during the pandemic, highlighting a public health crisis. Experts suggest that medication like QSYMIA can be a vital part of a broader strategy for those struggling with weight management.
Dr. Drew’s show covers important health topics, from recent medical breakthroughs to everyday health tips. It sparks conversations about our roles in improving our health and the health of our communities.
For more information about VIVUS and QSYMIA, visit their official website here and learn about how these treatments may benefit those dealing with weight challenges.
Check out this related article: Empowering Houston Moms: A Panel Discussion on Maternal Health for Latinas
Source linkVIVUS LLC
